General Information of the Compound
Compound ID |
CP0008601
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one;propionate(HCl)
Show/Hide
|
||||||||||||||||||
Synonyms |
Aldo
Aloperidin
Aloperidin (TN)
Aloperidol
Aloperidolo
Aloperidolo [DCIT]
Aloperidolo [Italian]
Aloperidon
Apo-Haloperidol
Bioperidolo
Bioperidolo (TN)
Brotopon
Brotopon (TN)
Dozic
Dozic (TN)
Dozix
Duraperidol (TN)
Einalon S
Einalon S (TN)
Eukystol
Eukystol (TN)
Fortunan
Galoperidol
H 1512
Haldol
Haldol (TN)
Haldol La
Haldol Solutab
Halidol
Halojust
Halol
Halopal
Haloperido
Haloperidol
Haloperidol (JP15/USP)
Haloperidol (JP15/USP/INN)
Haloperidol [USAN:INN:BAN:JAN]
Haloperidolum
Haloperidolum [INN-Latin]
Halopidol
Halopoidol
Halosten
Halosten (TN)
Keselan
Keselan (TN)
Lealgin compositum
Linton
Linton (TN);Novo-Peridol
McN-JR-1625
Mixidol
Pekuces
Peluces
Peluces (TN)
Peridol
Pernox
Pms Haloperidol
R 1625
R-1625
Serenace
Serenace (TN)
Serenase
Serenase (TN)
Serenelfi
Sernas
Sernel
Sigaperidol
Sigaperidol (TN)
Ulcolind
Uliolind
Vesalium
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C21H23ClFNO2
|
||||||||||||||||||
Molecular Weight |
375.871
|
||||||||||||||||||
Canonical SMILES |
OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2
Show/Hide
|
||||||||||||||||||
InChIKey |
LNEPOXFFQSENCJ-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
52-86-8
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Cell-based Assay
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Protein ID: PT01195, D(1A) dopamine receptor
Protein ID: PT01169, D(1B) dopamine receptor
Protein ID: PT01005, D(2) dopamine receptor
Cell-based Assay
Biochemical Assays
Protein ID: PT00957, D(2) dopamine receptor
Cell-based Assay
Biochemical Assays
Protein ID: PT01734, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Cell-based Assay
Protein ID: PT01366, D(3) dopamine receptor
Cell-based Assay
Protein ID: PT01161, D(4) dopamine receptor
Cell-based Assay
Protein ID: PT02591, Major prion protein
Protein ID: PT01515, Mu-type opioid receptor
Protein ID: PT01310, Muscarinic acetylcholine receptor M1
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Cell-based Assay
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Cell-based Assay
Protein ID: PT05156, Vesicular acetylcholine transporter
Cell Viability or Cytotoxicity Assay
Cell Line ID | Cell Line Name | Cell Line Organism | |
CL000683 | DAN-G | Homo sapiens (Human) | 1 |
1 |
IC50 > 20000 nM
|
TI
LI
LO
TS
|
---|
Clinical Information about the Compound
Drug 1 ( Haloperidol )
Drug Name | Haloperidol | ||
---|---|---|---|
Company | Janssen Pharmaceutica | ||
Indication | |||
Target(s) |
Dopamine D2 receptor (D2R)
Antagonist
|